These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34888347)

  • 1. Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Zhao H; Chan VW; Castellani D; Chan EO; Ong WLK; Peng Q; Moschini M; Krajewski W; Pradere B; Ng CF; Enikeev D; Vasdev N; Ekin G; Sousa A; Leon J; Guerrero-Ramos F; Tan WS; Kelly J; Shariat SF; Witjes JA; Teoh JY
    Front Surg; 2021; 8():775527. PubMed ID: 34888347
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
    Arends TJ; Nativ O; Maffezzini M; de Cobelli O; Canepa G; Verweij F; Moskovitz B; van der Heijden AG; Witjes JA
    Eur Urol; 2016 Jun; 69(6):1046-52. PubMed ID: 26803476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device-assisted intravesical chemotherapy versus bacillus Calmette-Guerin for intermediate or high-risk non-muscle invasive bladder cancer: a systematic reviewer and meta-analysis.
    You C; Li Q; Qing L; Li R; Wang Y; Cheng L; Dong Z
    Int Urol Nephrol; 2024 Jan; 56(1):103-120. PubMed ID: 37659995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance versus non-maintenance intravesical Bacillus Calmette-Guerin instillation for non-muscle invasive bladder cancer: A systematic review and meta-analysis of randomized clinical trials.
    Chen S; Zhang N; Shao J; Wang X
    Int J Surg; 2018 Apr; 52():248-257. PubMed ID: 29499363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
    Fujita N; Hatakeyama S; Momota M; Kido K; Narita T; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
    Urol Oncol; 2020 Aug; 38(8):684.e17-684.e24. PubMed ID: 32278732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Chou R; Selph S; Buckley DI; Fu R; Griffin JC; Grusing S; Gore JL
    J Urol; 2017 May; 197(5):1189-1199. PubMed ID: 28027868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose, duration and strain of bacillus Calmette-Guerin in the treatment of nonmuscle invasive bladder cancer: Meta-analysis of randomized clinical trials.
    Quan Y; Jeong CW; Kwak C; Kim HH; Kim HS; Ku JH
    Medicine (Baltimore); 2017 Oct; 96(42):e8300. PubMed ID: 29049231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial.
    Tan WS; Prendergast A; Ackerman C; Yogeswaran Y; Cresswell J; Mariappan P; Phull J; Hunter-Campbell P; Lazarowicz H; Mishra V; Rane A; Davies M; Warburton H; Cooke P; Mostafid H; Wilby D; Mills R; Issa R; Kelly JD
    Eur Urol; 2023 Jun; 83(6):497-504. PubMed ID: 35999119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS).
    Witjes JA; Palou J; Soloway M; Lamm D; Kamat AM; Brausi M; Persad R; Buckley R; Colombel M; Böhle A
    BJU Int; 2013 Oct; 112(6):742-50. PubMed ID: 23452187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis.
    Huang D; Jin YH; Weng H; Huang Q; Zeng XT; Wang XH
    Front Oncol; 2019; 9():121. PubMed ID: 30881921
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravesical radiofrequency-induced hyperthermia combined with chemotherapy for non-muscle-invasive bladder cancer.
    van Valenberg H; Colombo R; Witjes F
    Int J Hyperthermia; 2016 Jun; 32(4):351-62. PubMed ID: 26905963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining optimal maintenance schedules for adjuvant intravesical bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis.
    Huang Z; Liu H; Wang Y; Zhang C; Xu T
    Curr Med Res Opin; 2017 Aug; 33(8):1379-1387. PubMed ID: 28471272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E.
    Tan WP; Plata Bello A; Garcia Alvarez C; Guerrero-Ramos F; González-Padilla DA; Nzeh C; Manuel de la Morena J; de Torres IGV; Hendricksen K; Díaz Goizueta FJ; Del Álamo JF; Chiancone F; Fedelini P; Poggio M; Porpiglia F; Gonzalo Rodríguez VC; Torres JM; Wilby D; Robinson R; Sousa-Escandón A; Mata JL; Pontones Moreno JL; Molina FD; Adriazola Semino MA; Stemberger AT; Escudero JC; Redorta JP; Tan WS
    Bladder Cancer; 2022; 8(4):379-393. PubMed ID: 38994184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthermia intravesical chemotherapy acts as a promising alternative to bacillus Calmette-Guérin instillation in non-muscle-invasive bladder cancer: a network meta-analysis.
    Zeng N; Xu MY; Sun JX; Liu CQ; Xu JZ; An Y; Zhong XY; Ma SY; He HD; Xia QD; Wang SG
    Front Oncol; 2023; 13():1164932. PubMed ID: 37251942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
    Shelley MD; Court JB; Kynaston H; Wilt TJ; Coles B; Mason M
    Cochrane Database Syst Rev; 2003; (3):CD003231. PubMed ID: 12917955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence.
    Laukhtina E; Abufaraj M; Al-Ani A; Ali MR; Mori K; Moschini M; Quhal F; Sari Motlagh R; Pradere B; Schuettfort VM; Mostafaei H; Katayama S; Grossmann NC; Fajkovic H; Soria F; Enikeev D; Shariat SF;
    Eur Urol Focus; 2022 Mar; 8(2):447-456. PubMed ID: 33762203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guérin.
    Li R; Sundi D; Zhang J; Kim Y; Sylvester RJ; Spiess PE; Poch MA; Sexton WJ; Black PC; McKiernan JM; Steinberg GD; Kamat AM; Gilbert SM
    Eur Urol; 2020 Sep; 78(3):387-399. PubMed ID: 32143924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis.
    Houghton BB; Chalasani V; Hayne D; Grimison P; Brown CS; Patel MI; Davis ID; Stockler MR
    BJU Int; 2013 May; 111(6):977-83. PubMed ID: 23253618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
    Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R
    Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guérin for Ta and T1 bladder cancer: a systematic review and meta-analysis.
    Lu JL; Xia QD; Liu CQ; Sun JX; Yang YY; Hu HL; Wang SG
    Transl Cancer Res; 2021 Jun; 10(6):2849-2858. PubMed ID: 35116595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.